Center for Chemistry and Biomedicine, Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria; Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, 22060 Abbottabad, Pakistan.
Center for Chemistry and Biomedicine, Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria; Department of Pharmaceutics, Faculty of Pharmacy, University of Sargodha, 40100 Sargodha, Pakistan.
Int J Pharm. 2019 Apr 20;561:197-205. doi: 10.1016/j.ijpharm.2019.03.001. Epub 2019 Mar 2.
The aim of this study was to evaluate the impact of stability of hydrophobic ion pairs (HIPs) in gastrointestinal (GI) fluids on their release from self-emulsifying drug delivery systems (SEDDS). HIPs of leuprolide (LEU), insulin (INS) and bovine serum albumin (BSA) were formed using various mono- and di-carboxylate surfactants i.e. sodium deoxycholate (SDC), sodium dodecanoate (SDD), sodium stearoyl glutamate (SSG) and pamoic acid di-sodium salt (PAM). HIPs were evaluated regarding precipitation efficiency, log P and dissociation behavior at various pH and ionic strength. Solubility studies of these HIPs were accomplished to identify suitable solvents for the formulation of SEDDS. Subsequently, HIPs were incorporated into SEDDS followed by characterization regarding zeta potential, stability and log D. Independent from the type of (poly)peptides, PAM showed most efficient HIP properties among tested surfactants. The highest encapsulation efficiency with PAM was achieved at molar ratios of 1:1 for LEU, 1:3 for INS and 1:50 for BSA and log P of HIPs were increased at least 2.5 units. Dissociation studies showed that LEU-PAM, INS-PAM, BSA-PAM complexes were dissociated within 6 h up to 25%, 60% and 85% in GI fluids, respectively. These HIPs were successfully incorporated into SEDDS exhibiting negative zeta potential and high stability for 4 h. Log D of LEU-PAM, INS-PAM, BSA-PAM complexes were 2.4 ± 0.7, 2.1 ± 0.62 and 1.6 ± 0.45, respectively. Findings of this study showed that stability of HIPs has great impact on log D and consequently on their release from SEDDS.
本研究旨在评估疏水性离子对(HIPs)在胃肠道(GI)液中的稳定性对自乳化药物传递系统(SEDDS)中释放的影响。使用各种单羧酸和二羧酸表面活性剂,即脱氧胆酸钠(SDC)、十二烷酸钠(SDD)、谷氨酸单硬脂酰酯(SSG)和帕莫酸二钠盐(PAM),形成了亮丙瑞林(LEU)、胰岛素(INS)和牛血清白蛋白(BSA)的 HIPs。评估了 HIPs 的沉淀效率、log P 以及在不同 pH 值和离子强度下的解离行为。完成了这些 HIPs 的溶解度研究,以确定适合 SEDDS 配方的溶剂。随后,将 HIPs 掺入 SEDDS 中,然后对其进行zeta 电位、稳定性和 log D 进行表征。独立于(多)肽的类型,PAM 显示出在测试的表面活性剂中最有效的 HIP 特性。对于 LEU,用 PAM 获得的最高包封效率为摩尔比 1:1,对于 INS 为 1:3,对于 BSA 为 1:50,并且 HIP 的 log P 至少增加了 2.5 个单位。解离研究表明,LEU-PAM、INS-PAM、BSA-PAM 复合物在 GI 液中分别在 6 小时内解离至 25%、60%和 85%。这些 HIPs 成功地掺入 SEDDS 中,表现出负 zeta 电位和 4 小时的高稳定性。LEU-PAM、INS-PAM、BSA-PAM 复合物的 log D 分别为 2.4±0.7、2.1±0.62 和 1.6±0.45。本研究的结果表明,HIPs 的稳定性对 log D 以及 SEDDS 中它们的释放有很大影响。